World

Dubai hosts International Hybrid Congress of Joint Reconstruction Middle East

Apr 29, 2023

Dubai [UAE], April 29: Launched today in Dubai, the 10th Annual Meeting of the International Hybrid Congress of Joint Reconstruction Middle East (ICJR ME), brings together more that 1000 orthopedic experts from more than 25 countries all over the world to enhance professional knowledge, gain new insights and exchange expertise.
They will also discuss challenging Joint reconstruction cases, evidence based clinical experience ensuring the best outcomes in treatment through case studies.
Held from 28th to 30th April 2023, the annual meeting will feature three days of plenary interesting lectures, cutting-edge presentations, panel discussions, keynote addresses and instructional course lectures by leading experts in orthopedics and Q&A forum at the end of every session. Also an orthopedic nursing program will be running parallel to the congress.
In line with relentless pursuit for embracing innovative approaches and advancements, a major highlight at this year's congress will be Joint arthroplasty updates after Covid-19 Pandemic.
Dr. SamihTarabichi, Chairman - International Congress for Joint Reconstruction Middle East (ICJR ME), said the congress will provide an opportunity to unveil the recent advances and researches that are being carried out in the field of orthopedics in the world. It will also provide a platform for informative discussions and interactions as well as sharing knowledge, experience and to forge new collaborations though social activities during the congress.
Top notch regional and international experts will discuss updates in the fields of knee, hip, shoulder, foot, ankle, infection and innovation arthroplasty; and knee sports medicine.
Source: Emirates News Agency

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024